BioTime Announces the Issuance of 27 New Patents Protecting Stem Cell-Based … – Business Wire (press release)
|
BioTime Announces the Issuance of 27 New Patents Protecting Stem Cell-Based …
Business Wire (press release) United States patent 8,956,866 – “Retinal Pigment Epithelial Cells Differentiated from Embryonic Stem Cells with Nicotinamide and Activin A” discloses methods useful in the manufacture retinal pigment epithelial (RPE) cells such as OpRegen®, a product … |
